Staar Surgical Recap

What is your opinion of Staar Surgical?

Staar Surgical

NASDAQ:STAA - Apr. 21st 8:20am

$ 9.25 0.15 (1.65%)

Shares of Staar Surgical – a $358.9 million market cap Medical Instruments & Supplies company – have risen 1.65 percent to $9.25 as of 8:01 PM.

Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company develops, produces, and markets intraocular lenses. The Company was incorporated in the state of California in 1982. It was reincorporated in Delaware in 1986. The Company along with its subsidiaries designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The lenses are used in corrective or refractive surgery. The Company also makes lenses for use in surgery that treats cataracts. The Company operates as one operating segment, the ophthalmic surgical market. The Company maintains manufacturing and administrative facilities in the United States, Switzerland and Japan. The Company competes with other elective surgical procedures such as laser vision correction or LASIK, for those consumers who are looking for an alternative to eyeglasses or contact lenses to correct their vision.

Find out more about Staar Surgical.


Financials
Staar Surgical